Ann Hynes
Stock Analyst at Mizuho
(4.43)
# 358
Out of 5,015 analysts
258
Total ratings
65.1%
Success rate
13.25%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $300 → $430 | $354.50 | +21.30% | 21 | Oct 9, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $345 | $280.22 | +23.12% | 9 | Oct 9, 2025 | |
| ELV Elevance Health | Maintains: Outperform | $342 → $420 | $353.24 | +18.90% | 5 | Oct 9, 2025 | |
| CNC Centene | Maintains: Neutral | $28 → $40 | $35.76 | +11.86% | 9 | Oct 9, 2025 | |
| CVS CVS Health | Maintains: Outperform | $76 → $88 | $77.90 | +12.97% | 11 | Oct 9, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $32 → $22 | $24.26 | -9.32% | 12 | Aug 14, 2025 | |
| MEDP Medpace Holdings | Maintains: Outperform | $328 → $510 | $501.22 | +1.75% | 3 | Jul 25, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $190 → $225 | $198.17 | +13.54% | 13 | Jul 25, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $173 → $225 | $183.49 | +22.62% | 16 | Jul 25, 2025 | |
| THC Tenet Healthcare | Maintains: Outperform | $184 → $194 | $189.58 | +2.33% | 15 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $400 → $330 | $194.05 | +70.06% | 9 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $7 | $9.68 | -27.65% | 4 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $189 | $184.07 | +2.68% | 15 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $155 | $167.03 | -7.20% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $18 | $14.05 | +28.11% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $15.80 | -5.06% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $156.88 | -23.51% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $28.36 | -29.48% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $20.31 | +37.86% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $122.15 | -22.23% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $300.73 | +28.02% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $196.11 | +1.98% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $2.24 | +11,864.29% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $763.55 | -33.86% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $277.88 | -17.23% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $415.14 | -33.76% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $19.74 | +153.29% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.60 | +3,462.50% | 1 | Sep 21, 2017 |
UnitedHealth Group
Oct 9, 2025
Maintains: Outperform
Price Target: $300 → $430
Current: $354.50
Upside: +21.30%
Humana
Oct 9, 2025
Maintains: Outperform
Price Target: $300 → $345
Current: $280.22
Upside: +23.12%
Elevance Health
Oct 9, 2025
Maintains: Outperform
Price Target: $342 → $420
Current: $353.24
Upside: +18.90%
Centene
Oct 9, 2025
Maintains: Neutral
Price Target: $28 → $40
Current: $35.76
Upside: +11.86%
CVS Health
Oct 9, 2025
Maintains: Outperform
Price Target: $76 → $88
Current: $77.90
Upside: +12.97%
Acadia Healthcare Company
Aug 14, 2025
Maintains: Neutral
Price Target: $32 → $22
Current: $24.26
Upside: -9.32%
Medpace Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $328 → $510
Current: $501.22
Upside: +1.75%
IQVIA Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $198.17
Upside: +13.54%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $183.49
Upside: +22.62%
Tenet Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $184 → $194
Current: $189.58
Upside: +2.33%
Jul 11, 2025
Maintains: Outperform
Price Target: $400 → $330
Current: $194.05
Upside: +70.06%
Jul 11, 2025
Maintains: Neutral
Price Target: $8 → $7
Current: $9.68
Upside: -27.65%
Apr 9, 2025
Maintains: Outperform
Price Target: $178 → $189
Current: $184.07
Upside: +2.68%
Apr 9, 2025
Maintains: Neutral
Price Target: $175 → $155
Current: $167.03
Upside: -7.20%
Apr 9, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $14.05
Upside: +28.11%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $15.80
Upside: -5.06%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $156.88
Upside: -23.51%
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $28.36
Upside: -29.48%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $20.31
Upside: +37.86%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $122.15
Upside: -22.23%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $300.73
Upside: +28.02%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $196.11
Upside: +1.98%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $2.24
Upside: +11,864.29%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $763.55
Upside: -33.86%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $277.88
Upside: -17.23%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $415.14
Upside: -33.76%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $19.74
Upside: +153.29%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.60
Upside: +3,462.50%